Hedge Fund - Pura Vida Investments

Pura Vida Investments, based in New York and managed by Efrem Kamen since September 2012, specializes in healthcare investments. The hedge fund employs a long/short strategy focusing on medical technology, biotechnology, pharmaceuticals, and healthcare services.

Efrem Kamen serves as a Managing Member at Pura Vida Investments, a leading life sciences investment firm he co-founded in 2012. The firm specializes in healthcare investments across Medical Technology, Life Science Tools, and Biotechnology. Under Efrem's leadership, Pura Vida's flagship fund has garnered industry recognition, including awards such as Best Long Term 5-Year Performance in 2021, Best Long/Short Manager and Best Specialist Equity Manager in 2019, and Best US Emerging Fund Manager for Global Equities in 2018, as recognized by HFM Global (Absolute Return) and Pension Bridge. Efrem is also an Adjunct Associate Professor at Columbia Business School, where he developed and teaches a course on investing in medical technology, and serves as an Assistant Professor in Biomedical Engineering at Columbia Engineering School. He actively contributes to several organizations, including the Global Vitiligo Foundation, and through Pura Vida, supports initiatives with the Bowery Mission, The Skatepark Project, and the Jackie Robinson Foundation. Efrem serves as a Director of the National Cannabis Roundtable, advocating for federal cannabis reform. His extensive career includes roles as a Portfolio Manager at Waterfront Capital Partners, an Analyst at Diamondback Capital Management, LLC, focusing on medical device investments, and an Analyst at Citadel Investment Group in Chicago. Earlier experiences include positions as an Equity Research Analyst covering medical device companies at Cowen Group, Inc. and Citigroup, where he also conducted due diligence for public offerings and other transactions. Efrem began his career in Investment Banking at JP Morgan. Efrem graduated with Honors from Columbia College in New York, majoring in Economics and Linguistics.

Pura Vida Investments, a hedge fund managing assets totaling $263,973,004 for 12 clients as of March 2024, specializes in healthcare investments. Their Q1 2024 13F filing shows $593,263,734 in managed securities, with a top 10 holdings concentration of 74.27%. The fund's largest holding is iShares Russell 2000 ETF, with 705,000 shares held.